Improvements in Patient-Reported General Health and Well-Being in Patients With Primary Biliary Cholangitis Treated With Seladelpar in the RESPONSE Trial

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Improvements in Patient-Reported General Health and Well-Being in Patients With Primary Biliary Cholangitis Treated With Seladelpar in the RESPONSE Trial

	AASLD 2025 Nov 7-11 Wash DC Sonal Kumar,1